10 Years Manufacturer TU-1D01-100 thermal wax actuator for automobile thermostat to Southampton Factories
Short Description:
Product Detail
Product Tags
10 Years Manufacturer TU-1D01-100 thermal wax actuator for automobile thermostat to Southampton Factories Detail:
1. Operation Principle
The Thermostatic Wax that has been sealed in shell body induces expansion by a given temperature, and inner rubber seal part drives its handspike to move under expansion pressure to realize a transition from thermal energy into mechanical energy. The Thermostatic Wax brings an upward movement to its handspike, and automatic control of various function are realized by use of upward movement of handspike. The return of handspike is accomplished by negative load in a given returned temperature.
2. Characteristic
(1)Small body size, occupied limited space, and its size and structure may be designed in according to the location where needs to work.
(2)Temperature control is reliable and nicety
(3)No shaking and tranquilization in working condition.
(4)The element doesn’t need special maintenance.
(5)Working life is long.
3.Main Technical Parameters
(1)Handspike’s height may be confirmed by drawing and technical parameters
(2)Handspike movement is relatives to the temperature range of the element, and the effective distance range is from 1.5mm to 20 mm.
(3)Temperature control range of thermal wax actuator is between –20 ~ 230℃.
(4)Lag phenomenon is generally 1 ~ 2℃. Friction of each component part and lag of the component part temperature cause a lag phenomenon. Because there is a difference between up and down curve of traveling distance.
(5)Loading force of thermal wax actuator is difference, it depends on its’ shell size.
Product detail pictures:
With our leading technology as well as our spirit of innovation,mutual cooperation, benefits and development, we will build a prosperous future together with your esteemed company for 10 Years Manufacturer TU-1D01-100 thermal wax actuator for automobile thermostat to Southampton Factories, The product will supply to all over the world, such as: Luxembourg , Portland , Washington , Till now, the goods list has been updated regularly and attracted clients from around the globe. Detailed facts is often obtained in our web-site and you'll be served with premium quality consultant service by our after-sale group. They are going to help you get comprehensive acknowledge about our products and make a satisfied negotiation. Company go to to our factory in Brazil is also welcome at any time. Hope to obtain your inquiries for any pleased co-operation.
https://sarasotaford.vidmagnet.com/ava/apps/vsp.php?vehicle_fkey=ba2ac854-98eb-92e4-855e-4637a5345747
Sarasota Ford in Sarasota, Florida has a strong and committed sales staff with many years of experience satisfying their customers’ needs when looking for a New, Used, or Certified Pre-owned vehicle.
Sarasota Ford isn’t open 24 hours a day however, their dealership’s website is always open 24/7, 365 days a year! Sarasota Ford serves Sarasota, FL and the surrounding areas, helping customers find New, Used, or Certified Pre-owned vehicles.
New 2014 & 2015 Ford models:
2014 Ford Edge Limited – $41955
https://www.sarasotaford.com
For more information on this vehicle and our full inventory, call us at (888) 349-4989
Sarasota Ford
707 S. Washington Blvd
Sarasota FL 34236
Trailer Tow PKG. Driver Entry Package (Intelligent Access w/Push Button Start, Perimeter Alarm, and Power Liftgate), Vision Package (BLIS Blind Spot Information System, LED Turn Signal Mirror Indicators, and Rain Sensing Wipers), Edge Limited, 3.5L V6 Ti-VCT, 6-Speed Automatic with Select-Shift, 20 Chrome-Clad Aluminum Wheels, and Panoramic Vista Roof. This 2014 Edge is for Ford enthusiasts who are yearning for an exceptionally reliable SUV. It is nicely equipped with features such as Driver Entry Package (Intelligent Access w/Push Button Start, Perimeter Alarm, and Power Liftgate), Vision Package (BLIS Blind Spot Information System, LED Turn Signal Mirror Indicators, and Rain Sensing Wipers), 20 Chrome-Clad Aluminum Wheels, 3.5L V6 Ti-VCT, 6-Speed Automatic with Select-Shift, Edge Limited, Panoramic Vista Roof, Trailer Tow PKG, 12 Speakers, 3.16 Axle Ratio, 4-Wheel Disc Brakes, ABS brakes, Air Conditioning, AM/FM radio: SiriusXM, Auto-dimming Rear-View mirror, Automatic temperature control, Brake assist, Bumpers: body-color, CD player, Compass, Delay-off headlights, Driver door bin, Driver vanity mirror, Dual front impact airbags, Dual front side impact airbags, Electronic Stability Control, Four wheel independent suspension, Front anti-roll bar, Front Bucket Seats, Front Center Armrest w/Storage, Front dual zone A/C, Front reading lights, Fully automatic headlights, Garage door transmitter: HomeLink, Heated door mirrors, Heated front seats, Illuminated entry, Leather-Trimmed Heated Bucket Seats, Low tire pressure warning, Memory seat, MP3 decoder, Occupant sensing airbag, Outside temperature display, Overhead airbag, Overhead console, Panic alarm, Passenger door bin, Passenger vanity mirror, Power door mirrors, Power driver seat, Power passenger seat, Power steering, Power windows, Premium audio system: Sony, Radio data system, Radio: Sony AM/FM Stereo w/HD Radio/MyFord Touch, Rear anti-roll bar, Rear reading lights, Rear seat center armrest, Rear window defroster, Rear window wiper, Remote keyless entry, Speed control, Speed-Sensitive Wipers, Split folding rear seat, Spoiler, Steering wheel mounted A/C controls, Steering wheel mounted audio controls, SYNC w/MyFord Touch & SYNC Services, Tachometer, Telescoping steering wheel, Tilt steering wheel, Traction control, Trip computer, and Variably intermittent wipers. With tons of cargo room for you and your loved ones, you can haul everything you want, plus still have room to spare. We’re here to make your shopping experience as pleasant and hassle free as possible. Please call Sarasota Ford Internet Sales Manager @ 888-349-4989. Price includes: $1,000 – Ford Credit Retail Bonus Customer Cash, $500 – RETAIL Bonus Cash, $1,500 – RETAIL Customer Cash
Tumor Markers – Diagnostic Tests for Cancer – New ultra-sensitive platform sales@dmphotonics.com
Looking for partnerships!!!
New Molecular Diagnostics Biosensor features novel type of real-time microarrays that simultaneously detect protein, nucleic acid, and metabolite biomarkers. It requires no or minimal sample preparation and is capable of detecting from a single to several thousands of molecular markers in a small 50-microliter sample of biological fluid, including whole blood. Limit of Detection (LOD) for miRNA is 10^-18M. For proteins and metabolites LOD depends on the assay; for certain antibody-based assays LOD is at the level ~10^-15M. Broad dynamic range of the sensor covers the entire spectrum of clinically significant concentrations.
Classical microarrays operate with small, sub-monolayer amounts of antibodies and probe DNA immobilized on the surface. The signal from the sub-monolayer is small so the low light photodetector e.g. EMCCD camera is necessary for detection. New biosensor uses larger amounts of antibodies per unit area of bioassay spots. The signal is thousand-fold greater due to the use of patented substrate layer. Therefore, CCD cameras of cell phones are sensitive enough to detect the fluorescence signal.
We are looking for collaboration with researchers developing Molecular Diagnostics MDx systems based on fluorescent assays for development of extremely sensitive affordable Point-of-Service or Point-of-Care tools.
Email to sales@dmphotonics.com to learn more
New platform is 1000 times more sensitive than ELISA
The enzyme-linked immunosorbent assay (ELISA) is a test that uses antibodies and color change to identify a substance.
ELISA is a popular format of “wet-lab” type analytic biochemistry assay that uses a solid-phase enzyme immunoassay (EIA) to detect the presence of a substance, usually an antigen, in a liquid sample or wet sample.
The ELISA has been used as a diagnostic tool in medicine and plant pathology, as well as a quality-control check in various industries.
Antigens from the sample are attached to a surface. Then, a further specific antibody is applied over the surface so it can bind to the antigen. This antibody is linked to an enzyme, and, in the final step, a substance containing the enzyme’s substrate is added. The subsequent reaction produces a detectable signal, most commonly a color change in the substrate.
Performing an ELISA involves at least one antibody with specificity for a particular antigen. The sample with an unknown amount of antigen is immobilized on a solid support (usually a polystyrene microtiter plate) either non-specifically (via adsorption to the surface) or specifically (via capture by another antibody specific to the same antigen, in a “sandwich” ELISA). After the antigen is immobilized, the detection antibody is added, forming a complex with the antigen. The detection antibody can be covalently linked to an enzyme, or can itself be detected by a secondary antibody that is linked to an enzyme through bioconjugation. Between each step, the plate is typically washed with a mild detergent solution to remove any proteins or antibodies that are aspecifically bound. After the final wash step, the plate is developed by adding an enzymatic substrate to produce a visible signal, which indicates the quantity of antigen in the sample.
Prostate-specific antigen (PSA) blood test
Prostate-specific antigen (PSA) is a substance made by cells in the prostate gland (both normal cells and cancer cells). PSA is mostly found in semen, but a small amount is also found in the blood. Most healthy men have levels under 4 nanograms per milliliter (ng/mL) of blood. The chance of having prostate cancer goes up as the PSA level goes up.
When prostate cancer develops, the PSA level usually goes above 4. Still, a level below 4 does not guarantee that a man doesn’t have cancer — about 15% of men with a PSA below 4 will have prostate cancer on a biopsy. Men with borderline PSA level between 4 and 10 have about a 1 in 4 chance of having prostate cancer. If the PSA is more than 10, the chance of having prostate cancer is over 50%.
